Where can I find the specific financial results for Gilead Sciences for the quarter ended September 30, 2025?

The specific financial results for the quarter ended September 30, 2025, are detailed in the press release filed as Exhibit 99.1 to this 8-K report.

Why does Gilead present both GAAP and non-GAAP financial information?

Gilead presents non-GAAP financial measures because management believes they offer useful insights for investors when analyzed alongside GAAP results. These non-GAAP figures are used internally for operating, budgeting, and financial planning purposes.

How can I understand the differences between Gilead's GAAP and non-GAAP financial figures?

Gilead provides a reconciliation between its GAAP and non-GAAP financial information within the press release (Exhibit 99.1). Investors can find this reconciliation on pages 9, 10, and 11 of the press release.

Is the information in this 8-K report subject to the same liabilities as other SEC filings?

No, the information provided in Item 2.02 and Item 9.01 of this Form 8-K, as well as Exhibit 99.1, is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is therefore not subject to the liabilities under that section.

GILD 8-K: Earnings & Results

Summary

Gilead Sciences, Inc. (GILD) has filed an 8-K report on October 30, 2025, announcing its financial results for the quarter ended September 30, 2025. The report primarily directs investors to a press release (Exhibit 99.1) for detailed financial outcomes. Investors should review this press release to understand the company's performance in the most recent fiscal quarter. The company emphasizes the presentation of both GAAP and non-GAAP financial measures. Management considers the non-GAAP figures valuable for a deeper understanding of operational performance, as they are used for internal strategic planning. A crucial element for investors is the reconciliation provided within the press release, which bridges the differences between GAAP and non-GAAP reporting, allowing for a comprehensive financial assessment.

Key Highlights

1Gilead Sciences announced Q3 2025 financial results on October 30, 2025.
2Detailed financial results are provided in the press release filed as Exhibit 99.1.
3The company reported results using both GAAP and non-GAAP financial measures.
4Non-GAAP measures are presented as management uses them for operational and planning purposes.
5Investors are advised to consult the press release for the reconciliation between GAAP and non-GAAP figures.
6Information presented in this 8-K is not deemed 'filed' for Section 18 purposes.

GILEAD SCIENCES, INC. 8-K Report, Financial Results (Oct 30, 2025)

Summary

Key Highlights

Frequently Asked Questions